Search Results - Takuji Okusaka

Refine Results
  1. 1
    Immunotherapy for hepatocellular carcinoma: current status and future perspectives

    Immunotherapy for hepatocellular carcinoma: current status and future perspectives by Takuji Okusaka, Masafumi Ikeda

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines by Takuji Okusaka, Junji Furuse

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Phase II study of S-1 in patients with advanced biliary tract cancer

    Phase II study of S-1 in patients with advanced biliary tract cancer by Hideki Ueno, Takuji Okusaka, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions? by Masanori Mori, Chikako Shimizu, Asao Ogawa, Takuji Okusaka, Saran Yoshida, Tatsuya Morita

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Chemotherapy for hepatocellular carcinoma: current status and future perspectives

    Chemotherapy for hepatocellular carcinoma: current status and future perspectives by Masafumi Ikeda, Chigusa Morizane, Makoto Ueno, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    New developments in systemic therapy for advanced biliary tract cancer

    New developments in systemic therapy for advanced biliary tract cancer by Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT) by Junki Mizusawa, Chigusa Morizane, Takuji Okusaka, Hiroshi Katayama, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses

    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses by Toshiyuki Tamai, Seiichi Hayato, Seiichiro Hojo, Takuya Suzuki, Takuji Okusaka, Kenji Ikeda, Hiromitsu Kumada

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma by Shunsuke Kondo, Hideki Ueno, Hiroko Hosoi, Junichiro Hashimoto, Chigusa Morizane, Fumiaki Koizumi, Kenji Tamura, Takuji Okusaka

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer by Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi, Tatsuya Ioka, Junji Furuse, Shinichi Ohkawa, Hiroyuki Isayama, Narikazu Boku

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer

    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer by Shoichi Okada, Takuji Okusaka, Hiroshi Ishii, Akiko Kyogoku, Masayoshi Yoshimori, Naoko Kajimura, Ken Yamaguchi, Tadao Kakizoe

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future

    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future by Masafumi Ikeda, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Hideaki Takahashi, Kazuo Watanabe, Kumiko Umemoto, Takuji Okusaka

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer by Takuji Okusaka, Yukako Ιtο, Hideki Ueno, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane, Yoshikazu Kagami, Hiroshi Ikeda

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma

    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma by Masafumi Ikeda, Shinichi Ohkawa, Takuji Okusaka, Shuichi Mitsunaga, Satoshi Kobayashi, Chigusa Morizane, Ikue Suzuki, S. Yamamoto, Junji Furuse

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials by Juan W. Valle, Junji Furuse, Mark Jitlal, Sandy Beare, Nobumasa Mizuno, Harpreet Wasan, John Bridgewater, Takuji Okusaka

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection by Hiroshi Ishii, Shuichi Okada, Haruhiko Nose, Takuji Okusaka, Masayoshi Yoshimori, Tadatoshi Takayama, T Kosuge, Susumu Yamasaki, Michiie Sakamoto, S Hirohashi

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT) by Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, Junki Mizusawa, Junko Eba, Takuji Okusaka, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society

    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society by Takuji Okusaka, Satoaki Nakamura, Masahiro Yoshida, Masayuki Kitano, Katsuhiko Uesaka, Yoshinori Ito, Junji Furuse, Keiji Hanada, Kazuichi Okazaki

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506

    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506 by Hiroshi Ishii, J. Furuse, Narikazu Boku, Takuji Okusaka, Masafumi Ikeda, S. Ohkawa, Akira Fukutomi, Yasuo Hamamoto, K. Nakamura, Hiroyuki Fukuda

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies

    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies by Tal Grenader, Stephen Nash, Yevgeni Plotkin, Junji Furuse, Nobumasa Mizuno, Takuji Okusaka, Harpreet Wasan, Juan W. Valle, John Bridgewater

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: